Overview

Webcast ImageWebcast
Chromadex Corp at the Ladenburg Thalmann 2017 Healthcare Conference  (Live)
09/26/17 at 11:00 a.m. ET
Chromadex Corp at the Ladenburg Thalmann 2017 Healthcare Conference
Tuesday, September 26, 2017 11:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Where the power of nature meets the logic of science for the betterment of health.
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and acquire early stage, ingredient technologies that are protected by intellectual property.... More »

Stock Quote
NASDAQ - CDXC
Price$4.00
Change (%) Stock is Down 0.3 (6.98%)
Volume904,703
Refresh quote
Real-Time Level 2 Quote
Recent NewsMore »
DateTitle 
09/21/17ChromaDex to Present at the Ladenburg Thalmann 2017 Healthcare Conference
IRVINE, Calif., Sept. 21, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of science-based, proprietary health and wellness consumer products and ingredient technologies that promote health longevity announced today that its Chief Executive Officer and Co-Founder, Frank Jaksch and President and Chief Strategy Officer, Rob Fried will present at the Ladenburg Thalmann 2017 Healthcare Conference at the Sofitel Hotel in New York, New York. Mr. Jaksch and Mr. Fried are sched... 
Printer Friendly Version
09/18/17ChromaDex to Showcase Healthy Aging Ingredients and Phytochemical Reference Standards at SupplySide West 2017
IRVINE, Calif., Sept. 18, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of science-based, proprietary health and wellness consumer products and ingredient technologies that promote health longevity announced today that at this year’s SupplySide West, Sept. 26 through 28 in Las Vegas, it will showcase how its industry-advancing health and wellness ingredients can be positioned to help its customers’ healthy aging product innovations stand out in the marketplace. Attendees... 
Printer Friendly Version
09/07/17ChromaDex Partners with Asia’s Leading Health and Beauty Retailer, Watsons, for TRU NIAGEN™ Retail Launch
Hong Kong will be the Initial Market Launch, Soon to be Followed by Additional Asian Locations IRVINE, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of science-based, proprietary health and wellness consumer products and ingredient technologies that promote health longevity announced today its new partnership with Hong Kong based retailer, A.S. Watson, for the launch of the U.S. made TRU NIAGEN™ dietary supplement (www.truniagen.com) in Asia. With ove... 
Printer Friendly Version
Upcoming EventsMore »
DateTitle
09/26/17
11:00 a.m. ET
Chromadex Corp at the Ladenburg Thalmann 2017 Healthcare Conference
What's New
Download Documentation2017 Q2 Quarterly Report on Form 10Q
Download DocumentationSpecial Meeting – Proxy Statement
Download Documentation2017 Proxy Statement
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Chromadex Corp posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.